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ABSTRACT 
Background and aims: Preoperative prediction of both microinvasive hepatocellular 
carcinoma and histological grade of hepatocellular carcinoma is pivotal to treatment 
planning and prognostication. Aim of the study was to evaluate whether some 
intraoperative ultrasound features correlate with both the presence of same 
histological patterns and differentiation grade of hepatocellular carcinoma on the 
histologic features of the primary resected tumor. 
Methods: All patients with single, small hepatocellular carcinoma that underwent 
hepatic resection were included in this prospective double-blind study: the 
intraoperative ultrasound patterns of nodule were registered and compared with 
similar histological features.  
Results: 179 patients were enclosed in this study: 97 patients (54%) (34% in HCC <2 
cm) had a microinvasive hepatocellular carcinoma at ultrasound examination, while 
82 cases (46%) (41% in HCC <2 cm) at histological evaluation.  Statistical analysis 
showed that diameters <2 cm, presence of satellites and microinvasive 
hepatocellular carcinoma at ultrasound examination were the variables with the 
strongest association with the histologic findings. In the multivariate analysis, the 
vascular micro-infiltration and infiltrative hepatocellular carcinoma aspect were 
independent predictors for grading. 
Conclusions: In patients with liver cirrhosis and hepatocellular carcinoma, the 
prevalence of microinvasive hepatocellular carcinoma is high, even in cases of HCC 
<2 cm. Intraoperative ultrasound findings strongly correlated with histopathologic 
criteria in detecting microinvasive patterns and are useful to predict neoplastic 
differentiation.  The knowledge of these features prior to treatment are highly desired 
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(this can be obtained by an intraoperative ultrasound examination), as they could 
help in providing optimal management of patients with hepatocellular carcinoma. 
 
KEYWORDS: liver cirrhosis, hepatic resection, liver transplantation, radiofrequency 
ablation, vascular microinfiltration, hepatocellular carcinoma  
 
Key points box: 
 Disease recurrence after hepatic resection for hepatocellular carcinoma might be 
predicted by pathological findings such as differentiation degree, presence of 
satellites and the existence of vascular microinfiltration. 
 However, grade of hepatocellular carcinoma and aggressive patterns can be 
detect on surgical specimen. 
 This study shows that intraoperative ultrasound examination can intraoperatively 
identify ultrasound features of aggressive tumors 
 These patterns could influence clinical practice modifying the type of hepatic 
resection or the choice of ablation technology. Furthermore, they could be used to 
identify patients at high-risk for recurrence, and may improve the selection of 
patients undergoing transplantation 
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INTRODUCTION 
Disease recurrence after hepatic resection (HR) for hepatocellular carcinoma (HCC) 
might be predicted by pathological findings such as differentiation degree, presence 
of satellites and the existence of vascular microinfiltration. These features could 
allow patients to be shortlisted for liver transplantation without proven malignant 
disease (1-3). The presence of microinvasion (MI) defined as portal venous, hepatic 
vein, bile duct infiltration and/or intrahepatic metastasis (satellite nodules) is the best 
indicator of poor prognosis after HR and transplantation; in fact, in this study of 
Yamashita et al (4), the recurrence-free survival of the MI-positive group after HR 
was significantly worse than that of the MI-negative group. Furthermore, the 
histological grade of HCC is a significant prognostic factor after surgery and high-
grade HCC was found to be an independent predictor of vascular micro-infiltration 
(5-9). 
Therefore, preoperative prediction of both microinvasive hepatocellular carcinoma 
(MI-HCC) and histological grade of HCC is pivotal for treatment planning and 
prognostication. In this high-risk group of patients, prevention and treatment of 
recurrence could improve the data of survival (10-11). However, histological grade of 
HCC and MI patterns are difficult to detect preoperatively with the current advanced 
imaging modality. Recent studies have shown that positron emission tomography 
(12), diffusion-weighted magnetic resonance imaging (MRI) (13) and contrast 
enhanced ultrasound (14) can be used to predict the histological grade and/or the 
presence of MI. Furthermore, one study (15) showed that the use of noninvasive 
radiologic criteria can predict biology of HCC accurately and correlated radiologic 
patterns directly to outcome. Our recent study (15) suggested that HCC recurrence 
is associated with HCC nodules presenting more aggressive biologic behavior and 
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these patterns could be identified by the intraoperative ultrasound (IOUS) evaluation: 
IOUS remains as the best real-time imaging method for evaluation of HCC nodules 
during laparoscopic and open liver surgery 
In this prospective, double-blind study, we prospectively classified, for the first time 
to our knowledge, pattern combinations for each primary HCC nodule obtained by 
IOUS during HR. Then, we investigated whether these IOUS patterns correlate with 
both the presence of same histological patterns and differentiation grade of HCC on 
the histologic features of the primary resected tumor. 
 
PATIENTS AND METODHS 
Patients’ characteristics 
All patients had been assessed for disease staging with a pre-established protocol 
until 2000 (16); Barcelona Clinic Liver Cancer (BCLC) staging was retrospectively 
assessed in all patients enrolled before its accessibility (17).  
A multidisciplinary team, which includes surgeons, radiologists, and hepatologists 
determined patient’s eligibility for an invasive treatment. Criteria for staging and 
treatment evolved over-time. The diagnosis and staging of HCC were based on the 
appropriate imaging studies including triple-phase computed tomography (CT) 
and/or MRI according to the Barcelona-2000 European Association for the Study of 
the Liver (EASL) Conference, and histological assessment as required (18). 
Eligibility for liver transplantation (according to age, etiology, Child-Pugh and MELD 
score (Model for end-stage liver disease)) or HR was evaluated. Until 2012 (when 
the modified BCLC therapeutic algorithm was published (19)), HR was proposed 
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according to BCLC and AASLD guidelines: patients who had a single lesion can be 
offered surgical resection if they had cirrhosis with preserved liver function. Portal 
hypertension was not considered a contraindication in any case (20). Differing from 
the BCLC treatment protocol (19), in the time interval of this study we did not 
consider nodule size and number as absolute exclusion criteria from surgical 
treatment.  
In this series, the residual liver function was evaluated using the Child-Pugh 
classification (21) and MELD (model for end-stage liver disease) score (22). Upon 
referral, laboratory tests including complete blood cell count, coagulation profile, liver 
functions, plasma levels of alpha-fetoprotein (AFP), and a chest x-ray were 
performed. 
This study was approved by Institutional Review Board at Milan University. The 
patient records were anonymized and de-identified prior to analysis, and informed 
consent to storage the clinical data of patients with HCC was obtained from each 
participants. 
 
IOUS evaluation 
All patients underwent IOUS examination (Aloka Alfa 10; Aloka Co, Tokyo) during 
the operation. For laparotomic IOUS, T-shaped linear-type US probe was used at 
frequencies of both 5 MHz and 7.5 MHz, while for laparoscopic IOUS we used a 
laparoscopic ultrasound probe with a flexible tip, 10 mm in diameter and 50 cm in 
length and a 5 - 7.5 MHz linear-array transducer side-mounted near the tip of the 
shaft. IOUS image evaluation was performed by two blinded surgeons with more 
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than 10 years of experience using IOUS (R.S., M.B.), both of whom reviewed the 
sonographic images recorded on videotape and magneto-optical disks. In cases of 
discrepancies, the reviewers assessed the saved images together and reevaluated 
their findings to reach an agreement. They were unaware of the findings from the 
pathologic data during imaging evaluation. From the baseline IOUS features of the 
primary HCC nodule (15, 23), the surgeon was requested to classify the IOUS 
patterns according: diameter (registering also cut-off <20 mm), echogenicity 
(hyperechoic or hypoechoic), echotexture (homogeneous or inhomogeneous), 
nodular aspect (well-defined nodule versus infiltrative aspect) presence of 
pseudocapsule (hypoechoic or echogenic rim), capsular interruption (interruption of 
pseudocapsule + infiltrative aspect), mosaic architecture, nodule-in-nodule 
appearance, presence of satellites (identification of small nodules within 2cm away 
from HCC lesion) (Fig. 1A) and vascular/biliary micro-infiltration (either presence of 
vascular/biliary encasement or strict contact between vascular/biliary wall and nodule 
margins) (Fig 1C-1E). Number of HCC nodules was also considered: in this case, 
IOUS pattern has been determined for the largest nodule. According the histological 
definition proposed by Yamashita (4), MI-HCC was defined as a tumor with 
vascular/biliary infiltration and/or the presence of satellites. 
 
Histopathologic evaluation 
The pathology reports collected prospectively after surgery were used as a reference 
of standard for this study. All lesions were confirmed as HCC by surgical excision. 
Pathologists with hepatobiliary expertise who were blinded to the IOUS findings 
reviewed all histopathologic specimens. Tumor grade was scored using the modified 
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nuclear grading scheme outlined by Edmondson and Steiner (24): specifically, 
modified Edmondson–Steiner grades 1 and 2 were defined as well-differentiated, 
and grades 3 and 4 as moderately- and poorly-differentiated. In all cases, grade was 
defined by the poorest degree of differentiation identified within the tumor upon 
pathologic analysis of the entire specimen.  
For the comparison with the IOUS patterns already described, the pathologist was 
requested to classify the specimen according: diameter (registering also cut-off <20 
mm), presence of pseudocapsule versus infiltrative growth, capsular invasion 
(interruption of pseudocapsule and/or infiltrative aspect), nodule-in-nodule 
appearance, and vascular micro-infiltration (defined as presence of tumor emboli in a 
portal radicle vein, large capsular vessels or in a vascular space (25)). As described 
by Yamashita (4), MI-HCC was defined as vascular/biliary micro-infiltration (the 
presence of tumor cells within either a vascular space or a biliary duct that was 
visible only on microscopy) (Fig. 1D–1F) and/or the presence of satellites (Fig. 1B). 
Presence of cirrhosis was also confirmed on the surgical specimen.  
 
Statistical analysis 
The primary objective was to evaluate the ability of IOUS to depict the same 
pathological characteristics of HCC. The secondary objective was to determine 
whether IOUS patterns could be used to differentiate histopathologic grade of HCC. 
Data following a normal distribution were expressed as mean ± standard deviation. If 
data were non-parametric, median and interquartile range values were reported. 
Comparison of continuous variables between and within groups was performed by 
the Mann-Whitney U test and the Wilcoxon matched pairs test. Categorical variables 
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were analyzed by the Pearson’s chi-square test. Independent risk factors were 
identified by logistic regression. Factors significant at a p<0.10 in the univariate 
analyses were included in a multivariate analysis. 
Receiver operating characteristics (ROC) analyses were further constructed to 
determine the potential diagnostic performance for detecting the presence of MI. 
Corresponding areas under the ROC curve (AUC) with 95% confidence intervals 
(95% CI) were calculated. Sensitivity, specificity, positive (PPV) and negative 
predictive values (NPV) and likelihood ratios (PLR) were calculated for IOUS and 
histological evaluation using cross tabulations. For PLR, values above 10 indicate 
high predictive power, whereas values between 5 and 10 indicate good power; 
values below 5 indicate low predictive power and values around 1 indicate that no 
useful information for ruling the diagnosis in or out was produced. Agreement 
between IOUS patterns and surgical pathology were also reported using Cramer’s V 
method (the value of the level of association was interpreted as follows: 0.00, no 
relationship; 0.00–0.10, not generally useful; 0.10–0.20, weak; > 0.20–0.25, 
moderate; > 0.25–0.30, moderately strong; > 0.30–0.35, strong; > 0.35–0.40, very 
strong; > 0.40–0.45, worrisomely strong; > 0.45–9.99, redundant; and 1.00, perfect 
relationship). 
Initial evaluation, IOUS and histological data were collected in a dedicated database 
(FileMaker Pro for Macintosh; FileMaker Inc., Santa Clara, CA, USA) and 
subsequently analyzed (Intercooled Stata 14.1 for Macintosh, Stata Corp., College 
Station, TX, USA). 
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RESULTS 
We enrolled patients who underwent curative HR for HCC at our University Hospital 
between January 2005 and March 2016. From a total of 285 resected patients with 
HCC, 179 patients were enclosed in this study. Patients with HCC diameter higher 
than 5 cm (62 patients) and with evidence of vascular encasement at preoperative 
imaging (11 patients) were excluded. The remaining 33 patients did not have a 
complete IOUS or pathologic database schedule. The baseline characteristics of the 
enrolled patients are summarized in Table 1. 
In all patients IOUS has been accomplished: in 61 patients a laparoscopic IOUS 
probe was used, while a T-shaped probe was used in 118 subjects. New 
unsuspected lesions have been found in 23 patients (13%): in 10 cases (43% of the 
patients with new nodules) they were contiguous to primary HCC (satellite nodules), 
while in 13 cases (57%) they were located in other segments. For patients with new 
nodules contiguous to primary lesion, a IOUS-guided HR including these satellites 
has been accomplished, while for the others, we performed in 1 case (nodule in a 
contiguous segment) an enlarged HR, in 1 other case a second HR (nodule in other 
segment), in 6 cases an ethanol injection (nodule with a diameter less than 1 cm) 
and in the remaining 5 patients a RFA. 
The IOUS and histological data of the patients’ cohort are summarized in Table 2. 
After IOUS examination, MI-HCC was defined by the presence of biliary/vascular 
micro-infiltration and satellites in 20 cases (21%), by the only presence of vascular 
micro-infiltration in 55 cases (56%) and by the only presence of satellites in 22 cases 
(23%). Twenty-six cases out of the 54 with vascular micro-infiltration had vascular 
encasement with micro-thrombosis, while the other 28 cases showed only a strict 
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contact between HCC nodule and vessel wall. After histopathologic examination, MI-
HCC was defined by the presence of biliary/vascular micro-infiltration and satellites 
in 27 cases (33%), by the only presence of vascular micro-infiltration in 35 cases 
(43%) and by the only presence of satellites in 20 cases (24%). IOUS-guided HR 
has been performed in these cases in order to include in the surgical specimen all 
satellites and/or biliary/vascular microinfiltration: for these reasons, anatomical HR 
has been performed in 75% of patients with MI-HCC in comparison to 62% of 
patients without MI-HCC (p=0.059). 
Pathological examination revealed that 86 patients (48%) had a well-differentiated 
HCC, while the remaining 93 patients (52%) had a moderately/poorly-differentiated 
tumor. R0 resection was confirmed in all but 3 patients (1.7%), with median margin 
width of 5 mm (IR 2–10 mm). 
Sensitivity, specificity, and positive and negative predictive values of IOUS are listed 
in Table 3: results of statistical analysis showed that diameters, presence of satellites 
and MI-HCC at IOUS examination were the variables with the strongest association 
with the histologic findings. Laparoscopic IOUS confirmed to have the same ability in 
comparison with open IOUS to identify the same variables with the best association 
with the histologic features (diameters, presence of satellites and MI-HCC) (Table 4). 
In the subgroup of patients with HCC diameter <2 cm, presence of satellites, 
vascular microinfiltration and MI-HCC were the variables with the strongest 
association with the histologic features (Table 5). Table 6 shows the IOUS image 
findings that had a correlation with histologic grade: the percentage of 
moderately/poorly differentiated HCC was significantly higher for infiltrative aspect of 
nodule, capsular interruption, vascular micro-infiltration and MI-HCC. In the 
multivariate analysis, only the vascular micro-infiltration (OR: 4.824; 95% CI: 1.919-
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12.121; p=0.001) and infiltrative HCC aspect (OR: 2.313; 95% CI: 1.048-5.104; 
p=0.038) were independent predictors for HCC grading.  
 
DISCUSSION 
Several studies demonstrated that the presence of vascular micro-infiltration, 
satellites and/or high-grade HCC affects disease-free survival of patients with solitary 
HCC after curative HR (1, 4, 5, 7, 10, 11). Therefore, it is important to predict these 
features prior to treatment (in absence of a surgical specimen).  
The use of preoperative tumor biopsy is controversial both for the risk of 
complications which is due to associated coagulopathy and the possibility of tumor 
spreading and for the inter-observer variability to define the histologic grade. In fact, 
few studies have evaluated, with conflicting results, the accuracy of percutaneous 
biopsy in comparison with the surgical specimen: HCC tumor differentiation is not 
homogeneous (8, 26, 27) and vascular micro-infiltration is difficult to detect at the 
pre-operative biopsy (7, 9). 
Also due to these reasons, many factors and scoring systems evaluated by 
preoperative non-invasive procedures have been proposed to predict MI-HCC and/or 
HCC tumor differentiation (7, 28, 29). A study by Zhao et al. (30) demonstrated that 
serum AFP level >400 ng/L, serum GGT level >130 U/L, total tumor diameter >8 cm, 
and tumor number >3 were identified as independent predictors of vascular micro-
infiltration, but this retrospective analysis needs a prospective validation. On the 
other hand, vascular micro-infiltration is impossible to rule out before surgery even 
with the more recent imaging procedures, such as ultrasonography, CT, and MRI, 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
because it is a microscopic lesion. Some Authors (31) identified “worrisome” imaging 
features, such as non-smooth tumor margins, peritumoral enhancement, TTPVI 
(“internal arteries” and “hypoattenuating halos”), and large tumor size, which were 
significant predictors of the presence of vascular micro-infiltration in HCC. However, 
the retrospective design of this study needs a prospective validation, while its single-
center nature suggests substantial agreement among radiologists with a wide range 
of experience: in fact, other studies confirmed that there is no standard for MRI 
evaluation and the reproducibility of MRI features is still being investigated (32-34). 
Other studies demonstrate that preoperative 18F-FDG PET-TC is useful for predicting 
vascular micro-infiltration in small HCC (12). However, the low sensitivity of 18F-FDG 
PET-CT for detection of primary HCC was a major concern in the prestudy planning. 
In particular, well-differentiated and early HCC may not be detected using FDG-PET 
(12, 35). 
Yamashita et al (4) demonstrated that not only the presence of microinvasion such 
as portal venous, hepatic vein, bile duct infiltration, but also the presence of 
intrahepatic metastasis (satellites) is the best indicator of a poor prognosis after HR 
and transplantation. Therefore, MI-HCC may be considered an important entity (in 
line of principle superior to the only presence of vascular micro-infiltration) to 
determine the prognosis of patients submitted not only to HR or liver transplantation 
(4, 7, 36) but also to ablation therapies (37-39). Our study showed that IOUS 
definition of MI-HCC had a high agreement with the histological findings, such as the 
satellites detection and the correct measurement of HCC diameter (see table 3) and 
the type of IOUS examination (through either a laparoscopic or an open approach) 
did not influence these results (see table 4). This analysis is also valid in the 
subgroup of patients with HCC diameter <2 cm (see table 5). It is important to outline 
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that vascular microinfiltration showed weaker correlation with histological features: 
the main reason is intrinsic to IOUS definition of “vascular micro-infiltration” that is 
either presence of vascular encasement or strict contact between vascular wall and 
nodule margins. In this last case, it is possible that the contact with vascular wall 
does not represent a histologic encasement (Fig. 2). Furthermore, multivariate 
analysis showed that vascular micro-infiltration and infiltrative HCC aspect are 
related to tumor differentiation. 
Therefore, IOUS examination during surgical procedures can identify more 
aggressive HCC nodule and this could influence clinical practice in different settings. 
For patients with HCC candidates to radiofrequency ablation (RFA), if preoperative 
clinical, biological and/or radiological features identified “worrisome” signs of 
aggressive behavior of HCC nodule, it could be preferable to propose a laparoscopic 
approach in order to accomplish IOUS evaluation. This examination is valid also for 
patients with HCC diameter <2 cm (4, 39). 
During a laparoscopic thermo-ablation treatment, laparoscopic IOUS permits to 
identify MI-HCC tumors: in these cases, a microwave ablation instead of RFA could 
lead to a further clearance of possible residues of vascular micro-infiltration and 
satellite micronodules by ablating more viable tumor containing liver parenchyma 
and decrease probability of metastasis of the residual tumor cell by intrahepatic 
portal vein (40, 41). 
During a HR, if a MI-HCC has been detected, it is possible to modify the surgical 
strategy and an anatomic HR or a partial HR with a wide tumor margin should be 
accomplished (36, 42). Anatomic resection can ideally eradicate MI-HCC confined to 
tumor-bearing portal tributaries (43). 
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Finally, during a surgical RFA of HCC, the IOUS evaluation of tumor patterns 
identified some HCC features, which could predict the HCC tumor differentiation: 
vascular micro-infiltration and infiltrative aspect at IOUS examination were well 
correlated with moderately/poorly differentiated HCC. This information could be used 
to identify patients at high-risk for HCC recurrence, and may improve the selection 
and survival of patients undergoing transplantation for HCC (3, 5, 6). 
With recent improvements in technology, IOUS has now become an indispensable 
means of defining the extent of disease and resectability, and providing a guide to 
anatomic and nonanatomic HR and minimally invasive and ablative techniques. This 
study demonstrated that IOUS can also furnish important information about the 
prediction of HCC recurrences.  However, the most important bias for the clinical 
application of these results is due to the fact that IOUS is an operator-dependent 
technique: with proper training, surgeons can accurately perform and interpret IOUS 
examinations and then use the results in the management of HCC patients. 
In conclusion, HCC grading and vascular micro-infiltration is accepted worldwide as 
the two most important predictors of prognosis in patients with HCC both after HR 
and transplantation. The knowledge of these features prior to treatment are highly 
desired (and this can be obtained by the IOUS examination), as they could help in 
providing optimal management of HCC patients. In any case, these IOUS 
parameters could further increase prognostic precision in estimating the post-OLT 
risk of tumor recurrence, substantially improving the patient selection process. 
Further studies are necessary to evaluate if these IOUS features are directly 
predictive of intra-hepatic HCC recurrences. 
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LEGEND OF FIGURES 
Fig. 1: Intraoperative ultrasound images show HCC nodule with satellites (A), strict 
contact between vascular wall and nodule margin (C) and biliary microinfiltration 
(with dilated bile duct) (E). B: photograph of a resected specimen shows a nodular 
HCC with satellites, D: photomicrograph (H and E stain, x40) reveals vascular 
microinfiltration. F: photomicrograph (H and E stain, x40) shows HCC nodule with 
invasion of the bile duct and dilated bile duct 
HCC: hepatocellular carcinoma; s: satellite; VMI: vascular microinfiltration; DBD: 
dilated bile duct 
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Fig. 2: intraoperative ultrasound imaging of strict contact between HCC nodule 
margins and vascular wall, which is considered as vascular microinfiltration (A); at 
histological examination, no vascular encasement is found (B and C) 
(photomicrograph, (H and E stain, x10 and x40) 
HCC: hepatocellular carcinoma; VMI: vascular microinfiltration 
 
 
 
 
  
 All patients (n=179) 
Male sex  129 (72%) 
Age (years) (median; IR) 69.68.6 (71; 65-75) 
Cirrhosis etiology   
HCV 120 (67%) 
HBV 31 (17%) 
Other 28 (16%) 
Child-Pugh Class A5 
                   Class A6 
                   Class B7 
132 (74%) 
44 (24%) 
3 (2%) 
MELD score (median; IR) 8.41.7 (8; 7-9) 
BCLC [3]  
A1 100 (56%) 
A2 32 (18%) 
A3 14 (8%) 
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A4 33 (18%) 
Esophageal varices 44 (25%) 
Diabetes 58 (32%) 
Previous HCC (already treated) 33 (18%) 
HCC nodule: single /multiple 150 (84%)/ 29 (16%) 
HCC lesion diameter (mm) (Median, IR) 27.510.4 (26; 20-34) 
Platelet count (x100/mm3) (Median, IR) 13256 (126; 89-169) 
Total bilirubin (mg/dl) (Median, IR) 1.050.50 (1; 0.7-1.3) 
Serum albumin (g/l) (Median, IR) 4.020.49 (4.06; 3.67-4.4) 
Prothrombin time (INR) (Median, IR) 1.110.12 (1.09; 1.03-1.16) 
AST (U/L) (Median, IR) 63+50 (47; 30-82) 
ALT (U/L) (Median, IR) 66+54 (46; 30-84) 
CHE (U/L) (Median, IR) 5976+2235 (5872; 4492-7228) 
ALP (U/L) (Median; IR) 143+93 (110; 75-189) 
Alpha-fetoprotein (ng/ml)  (median, IR) 72+240 (7.5; 3.4–26.6) 
 
 
 
Table 1. Baseline characteristics of the study population   
IR: interquartile range; HCV: Hepatitis C virus; HBV: Hepatitis B virus; MELD: Model for end-
stage liver disease; BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; 
AST: Aspartate aminotransferase; ALT: alanine aminotransferase; CHE: cholinesterase; 
ALP: alkaline phosphatase 
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Table 2: IOUS and histopathologic patterns 
IOUS: intraoperative ultrasound, HCC: hepatocellular carcinoma, MI-HCC: microinvasive 
hepatocellular carcinoma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables IOUS  Histopathology  
HCC diameter (mm) 
(median, IR) 
26.7 + 10.6 
(24; 19-34) 
26.2 + 11.5 
(25; 17-33) 
Very Early (<2cm) 68 (38%) 70 (39%) 
Pseudocapsule 130 (73%) 109 (61%) 
Capsular interruption 120 (67%) 148 (83%) 
Infiltrative growth 49 (27%) 76 (42%) 
Nodule-in-nodule appearance 48 (27%) 10 (6%) 
Satellites 42 (23%) 47 (26%) 
Vascular micro-infiltration 75 (42%) 62 (35%) 
MI-HCC 97 (54%) 82 (46%) 
MI-HCC (HCC nodule <2cm) 23 (34%) 29 (41%) 
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Table 3: Intraoperative ultrasound image findings in relation to pathologic features of 
hepatocellular carcinoma 
Diam: diameter; Mi-HCC microinvasive hepatocellular carcinoma; PPV: positive predictive 
value; NPV negative predictive value; PLR: positive likelihood ratio; OR: odds ratio; IC: 
interval of confidence; AUCs: area under curves 
 
 
 
 
 
 
 
 
 
IOUS features Sensiti
vity 
Specifi
city 
PPV NPV PLR CRAMER 
V 
Diagnostic 
OR (IC 
95%) 
AUCs (IC 
95%) 
Diam <20mm 91 83 89 85 5.3 0.7408 47.8 (17.9 – 
132.3) 
0.87 (0.82-
0.92) 
Pseudocapsule 40 81 57 81 2.1 0.2269 2.8 (1.3 – 
5.8) 
0.60 (0.53-
0.67) 
Capsular 
interruption 
72 55 88 29 1.6 0.2130 
3.1 (1.3 – 
7.3) 
0.63 (0.54-
0.73) 
Infiltrative growth 
43 85 67 67 2.8 0.3091 
4.2 (1.9 - 
8.9) 
0.63 (0.57-
0.71) 
Nodule-in-nodule 
appearance 
80 76 17 98 3.4 0.2920 12.9 (2.4 – 
92) 
0.78 (0.65-
0.92) 
Satellites 72 94 81 91 11.9 0.6882 40.5 (14.2 – 
120.5) 
0.86 (0.79-
0.92) 
Vascular micro-
infiltration 
76 76 63 86 3.2 0.5003 9.9 (4.6 – 
21.9) 
0.74 (0.68-
0.80) 
MI-HCC 93 78 78 93 4.3 0.7424 45.8 (16.3-
136.4) 
0.85 (0.80-
0.90) 
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IOUS 
features 
PLR CRAMER V Diagnostic OR (IC 
95%) 
AUCs (IC 95%) 
 LPS 
IOU
S 
Ope
n 
IOU
S 
LPS 
IOUS 
Open 
IOUS 
LPS IOUS Open 
IOUS 
LPS IOUS Open IOUS 
Diam <20mm 22.2 3.7 0.782
2 
0.722
1 
121 (12-
2924) 
51 (14-
216) 
0.89 
(0.82-
0.97) 
0.84 (0.77-
0.92) 
Pseudocapsul
e 
2.9 1.7 0.337
9 
0.165
6 
4.6 (1.2-
17.9) 
2.1 (0.9-
5.3) 
0.65 
(0.54-
0.77) 
0.58 (0.49-
0-66) 
Capsular 
interruption 
1.2 1.9 0.084
6 
0.275
3 
1.6 (0.3-
7.8) 
4.2 (1.4-
12.7) 
0.55 
(0.38-0-
72) 
0.67 (0.55-
0.78) 
Infiltrative 
growth 
2.4 3.1 0.269
6 
0.328
9 
3.4 (0.9-
12.7) 
4.7 (1.8-
12.4) 
0.62 
(0.51-
0.74) 
0.65 (0.56-
0.73) 
Nodule-in-
nodule 
appearance 
3.2 3.4 0.236
4 
0.315
5 
7.7 (0.5-
235) 
17.8 (1.9-
410) 
0.73 (0.4-
1) 
0.80 (0.66-
0-95) 
Satellites 4.9 5.4 0.460
8 
0.554
3 
12.9 (2.1-
88.1) 
15 (5.1-
45.6) 
0.77 
(0.59-
0.94) 
0.78 (0.69-
0.87) 
Vascular 
micro-
infiltration 
4.6 2.2 0.469
6 
0.376
9 
10 (2.2-49) 5.2 (2.1-
12.9) 
0.73 
(0.60-0-
87) 
0.69 (0.61-
0.78) 
MI-HCC 9.7 3.5 0.825
7 
0.687
8 
175 (16-
4688) 
40 (11-
157) 
0.93 
(0.86-
099) 
0.84 (0.77-
0.90) 
 
Table 4: Intraoperative ultrasound image findings in relation to pathologic features of 
hepatocellular carcinoma for patients submitted to laparoscopic IOUS or open IOUS 
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Diam: diameter; Mi-HCC microinvasive hepatocellular carcinoma; LPS: laparoscopic; 
IOUS: intraoperative ultrasound; PLR: positive likelihood ratio; OR: odds ratio; IC: 
interval of confidence; AUCs: area under curves 
 
 
 
 
Table 5: Intraoperative ultrasound image findings in relation to pathologic features of 
hepatocellular carcinoma < 2 cm 
MI-HCC microinvasive hepatocellular carcinoma; PPV: positive predictive value; NPV 
negative predictive value; PLR: positive likelihood ratio; OR: odds ratio; IC: interval of 
confidence; AUCs: area under curves 
 
 
 
 
 
 
IOUS features Sensitivity Specificity PPV NPV PLR CRAMER 
V 
Diagnostic 
OR (IC 95%) 
AUCs (IC 
95%) 
Pseudocapsule 39 78 67 53 1.8 0.1838 2.3 (0.7 – 
7.7) 
0.60 (0.47-
0.75) 
Capsular 
interruption 
61 45 85 19 1.3 0.0516 
1.3 (0.3 – 
5.7) 
0.52 (0.43-
0.61) 
Infiltrative 
growth 
42 78 62 62 1.9 0.2190 
2.7 (0.9 - 
8.7) 
0.62 (0.49-
0.75) 
Nodule-in-
nodule 
appearance 
33 83 8 96 1.9 0.0884 2.5 (0.1 – 
40) 
0.52 (0.44-
0.61) 
Satellites 71 98 92 91 36 0.7557 120 (11.4 –
3072.6) 
0.92 (0.81-
1) 
Vascular micro-
infiltration 
57 93 67 89 7.7 0.5275 16.7 (3.2 – 
97.5) 
0.78 (0.63-
0.92) 
MI-HCC 87 95 91 93 19.2 0.8379 147 (18.6-
1711.2) 
0.92 (0.85-
0.99) 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
IOUS features Well-
differentiated 
Moderately/poorly 
differentiated 
p 
Infiltrative aspect 14 (16%) 35 (38%) 0.001 
Capsular interruption 51 (59%) 69 (74%) 0.034 
Nodule-in-nodule appearance 20 (23%) 28 (30%) NS 
Satellites 22 (26%) 20 (22%) NS 
Vascular micro-infiltration  23 (27%) 52 (56%) 0.0001 
MI-HCC 38 (44%) 59 (63%) 0.010 
 
Table 6: Intraoperative ultrasound image findings in relation to pathologic grading of 
hepatocellular carcinoma 
IOUS: intraoperative ultrasound; MI-HCC: microinvasive hepatocellular carcinoma 
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